Review of epidermal growth factor receptor-tyrosine kinase inhibitors administration to non-small-cell lung cancer patients undergoing hemodialysis.

Lan, Chou-Chin; Hsieh, Po-Chun; Huang, Chun-Yao; Yang, Mei-Chen; Su, Wen-Lin; Wu, Chih-Wei; Wu, Yao-Kuang

Lan, Chou-Chin; Hsieh, Po-Chun; Huang, Chun-Yao; Yang, Mei-Chen; Su, Wen-Lin; Wu, Chih-Wei; Wu, Yao-Kuang.

Afiliación

Lan CC; Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan.
Hsieh PC; Department of Chinese Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan.
Huang CY; Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan.
Yang MC; Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan.
Su WL; Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan.
Wu CW; Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan.
Wu YK; Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 23142, Taiwan. drbfci@yahoo.com.tw.

World J Clin Cases ; 10(19): 6360-6369, 2022 Jul 06.

Article en En | MEDLINE | ID: mdl-35979322

Palabras clave

Epidermal growth factor receptor; Hemodialysis; Non-small-cell lung cancer; Tyrosine-kinase inhibitors

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: World J Clin Cases Año: 2022 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google